Cases 1 - 10 of 69
Zetia (Ezetimibe) Antitrust v. Merck & Company, Incorporated
as 20-2184
Defendant / Appellant:
MERCK & COMPANY, INCORPORATED, MSP SINGAPORE CO. LLC, MERCK SHARP & DOHME CORPORATION and others
Not Classified By Court:
In re: ZETIA (EZETIMIBE) ANTITRUST LITIGATION
Plaintiff / Appellee:
CESAR CASTILLO, INC., individually and on behalf of all those similarly situated, FWK HOLDINGS, LLC, ROCHESTER DRUG COOPERATIVE, INC., ON BEHALF OF ITSELF AND ALL OTHERS SIMILARLY SITUATED and others
Merck & Co., Inc. v. FWK Holdings, LLC
as 20-432
Respondent:
THE RETIRED FIREFIGHTERS' SECURITY BENEFIT FUND OF THE UNIFORMED FIREFIGHTERS' ASSOCIATION, on behalf of themselves and all others similarly situated, INTERNATIONAL UNION OF OPERATING ENGINEERS LOCAL 49 HEALTH & WELFARE FUND, WALGREEN CO. and others
Petitioner:
SCHERING CORPORATION, SCHERING PLOUGH CORPORATION, MERCK SHARP & DOHME CORPORATION and others
Not Classified By Court:
In re: ZETIA (EZETIMIBE) ANTITRUST LITIGATION
In Re: Actos Direct Purchaser
as 20-2002
Plaintiff / Appellee:
American Sales Company, LLC, on behalf of itself and all others similarly situated, Meijer Distribution, Inc., Cesar Castillo, Inc., Individually and on behalf of all those similarly situated and others
Defendant / Appellant:
Takeda Pharmaceutical Company Limited, Takeda America Holdings, Inc., Takeda Development Center Americas, Inc. and others
CESAR CASTILLO, INC. et al v. ACTAVIS HOLDCO U.S., INC. et al
as 2:2020cv00721
Plaintiff:
KPH HEALTHCARE SERVICES, INC., CESAR CASTILLO, INC., FWK HOLDINGS, L.L.C. and others
Defendant:
BAUSCH HEALTH AMERICAS, INC., HERITAGE PHARMACEUTICALS, INC., AMNEAL PHARMACEUTICALS, LLC and others
Cause Of Action: 15 U.S.C. § 1
Takeda Pharmaceutical Company v. American Sales Company, LLC
as 20-485
Respondent:
Cesar Castillo, Inc., Individually and on behalf of all those similarly situated, Meijer, Inc., Meijer Distribution, Inc. and others
Petitioner:
Takeda Pharamceuticals, U.S.A., Inc., Takeda Development Center Americas, Inc., Takeda America Holdings, Inc. and others
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
as 1:2019md02895
Not Classified By Court:
UFCW Local 1500 Welfare Fund, Actavis Pharma Inc., Cipla Ltd. and others
Plaintiff:
Cesar Castillo, Inc. and KPH HEALTHCARE SERVICES, INC.
In Re:
In re: Sensipar (Cinacalcet Hydrochloride Tablets) Antitrust Litigation
Cause Of Action: 15 U.S.C. § 1
Mennonite General Hospital, Inc. et al v. Purdue Pharma, L.P. et al
as 1:2019op45109
Defendant:
CESAR CASTILLO, INC., Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Anda, Inc. and others
Plaintiff:
MENNONITE GENERAL HOSPITAL, INC., HOSPITAL MENONITA CAGUAS, INC., HOSPITAL MENONITA GUAYAMA, INC. and others
Cause Of Action: 18 U.S.C. § 1961
Cesar Castillo, Inc. v. Amgen Inc. et al
as 1:2019cv00396
Defendant:
Teva Pharmaceuticals USA, Inc., Watson Pharmaceuticals, Inc., Amgen Inc. and others
Plaintiff:
Cesar Castillo, Inc.
Cause Of Action: 15 U.S.C. § 1
Cesar Castillo, Inc. v. Ranbaxy Inc. et al
as 1:2019cv10357
Defendant:
Ranbaxy U.S.A. Inc., Ranbaxy Inc., RANBAXY LABORATORIES, LTD. and others
Plaintiff:
Cesar Castillo, Inc.
Cause Of Action: 18 U.S.C. § 1962
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
as 1:2019md02878
In Re:
Ranbaxy Generic Drug Application Antitrust Litigation
Plaintiff:
Meijer, Inc., Meijer Distribution, Inc., Cesar Castillo, Inc. and others
Defendant:
Ranbaxy Laboratories Limited, Sun Pharmaceutical Industries Limited, Ranbaxy, Inc. and others
Consolidated Plaintiff:
United Food and Commercial Workers Health and Welfare Fund of Northern Pennsylvania and Louisiana Health Services and Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana
Respondent:
Prinston Pharmaceutical Inc.
Interested Party:
Novartis Pharmaceuticals Corporation and Astrazeneca Pharmaceuticals L.P.
Not Classified By Court:
Winifred Weitsen
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
